BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 11715952)

  • 1. Technology evaluation: cystic fibrosis therapy, Genzyme.
    Cockett MI
    Curr Opin Mol Ther; 1999 Apr; 1(2):279-83. PubMed ID: 11715952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis.
    Hyde SC; Southern KW; Gileadi U; Fitzjohn EM; Mofford KA; Waddell BE; Gooi HC; Goddard CA; Hannavy K; Smyth SE; Egan JJ; Sorgi FL; Huang L; Cuthbert AW; Evans MJ; Colledge WH; Higgins CF; Webb AK; Gill DR
    Gene Ther; 2000 Jul; 7(13):1156-65. PubMed ID: 10918483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Aerosol administration of a replication defective recombinant adenovirus expressing normal human cDNA-CFTR in the respiratory tractus in patients with cystic fibrosis].
    Bellon G; Calmard L; Thouvenot D; Levrey H; Jagneaux V; Poitevin F; Malcus C; Accart N; Séné C; Layani MP; Aymard M; Bienvenu J; Courtney M; Döring G; Gilly B; Gilly R; Lamy D; Morel Y; Paulin C; Perraud F; Rodillon L; So S; Touraine F; Schatz C; Pavirani A
    C R Seances Soc Biol Fil; 1996; 190(1):109-42. PubMed ID: 8881273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of a single aerosol administration of escalating doses of the cationic lipid GL-67/DOPE/DMPE-PEG5000 formulation to the lungs of normal volunteers.
    Chadwick SL; Kingston HD; Stern M; Cook RM; O'Connor BJ; Lukasson M; Balfour RP; Rosenberg M; Cheng SH; Smith AE; Meeker DP; Geddes DM; Alton EW
    Gene Ther; 1997 Sep; 4(9):937-42. PubMed ID: 9349430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of DNA-lipid complexes and DNA alone for gene transfer to cystic fibrosis airway epithelia in vivo.
    Zabner J; Cheng SH; Meeker D; Launspach J; Balfour R; Perricone MA; Morris JE; Marshall J; Fasbender A; Smith AE; Welsh MJ
    J Clin Invest; 1997 Sep; 100(6):1529-37. PubMed ID: 9294121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cationic lipid:pDNA complexes for the treatment of cystic fibrosis.
    Eastman SJ; Scheule RK
    Curr Opin Mol Ther; 1999 Apr; 1(2):186-96. PubMed ID: 11715942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gene therapy in mucoviscidosis].
    Schatz C; Pavirani A
    Rev Pneumol Clin; 1995; 51(3):201-6. PubMed ID: 7569584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A placebo-controlled study of liposome-mediated gene transfer to the nasal epithelium of patients with cystic fibrosis.
    Gill DR; Southern KW; Mofford KA; Seddon T; Huang L; Sorgi F; Thomson A; MacVinish LJ; Ratcliff R; Bilton D; Lane DJ; Littlewood JM; Webb AK; Middleton PG; Colledge WH; Cuthbert AW; Evans MJ; Higgins CF; Hyde SC
    Gene Ther; 1997 Mar; 4(3):199-209. PubMed ID: 9135733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sendai virus-mediated CFTR gene transfer to the airway epithelium.
    Ferrari S; Griesenbach U; Iida A; Farley R; Wright AM; Zhu J; Munkonge FM; Smith SN; You J; Ban H; Inoue M; Chan M; Singh C; Verdon B; Argent BE; Wainwright B; Jeffery PK; Geddes DM; Porteous DJ; Hyde SC; Gray MA; Hasegawa M; Alton EW
    Gene Ther; 2007 Oct; 14(19):1371-9. PubMed ID: 17597790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technology evaluation: AAV-CFTR vector, targeted genetics.
    Tebbutt SJ
    Curr Opin Mol Ther; 1999 Aug; 1(4):524-9. PubMed ID: 11713770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-clinical evaluation of three non-viral gene transfer agents for cystic fibrosis after aerosol delivery to the ovine lung.
    McLachlan G; Davidson H; Holder E; Davies LA; Pringle IA; Sumner-Jones SG; Baker A; Tennant P; Gordon C; Vrettou C; Blundell R; Hyndman L; Stevenson B; Wilson A; Doherty A; Shaw DJ; Coles RL; Painter H; Cheng SH; Scheule RK; Davies JC; Innes JA; Hyde SC; Griesenbach U; Alton EW; Boyd AC; Porteous DJ; Gill DR; Collie DD
    Gene Ther; 2011 Oct; 18(10):996-1005. PubMed ID: 21512505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis.
    Zabner J; Ramsey BW; Meeker DP; Aitken ML; Balfour RP; Gibson RL; Launspach J; Moscicki RA; Richards SM; Standaert TA
    J Clin Invest; 1996 Mar; 97(6):1504-11. PubMed ID: 8617884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and biological efficacy of a lipid-CFTR complex for gene transfer in the nasal epithelium of adult patients with cystic fibrosis.
    Noone PG; Hohneker KW; Zhou Z; Johnson LG; Foy C; Gipson C; Jones K; Noah TL; Leigh MW; Schwartzbach C; Efthimiou J; Pearlman R; Boucher RC; Knowles MR
    Mol Ther; 2000 Jan; 1(1):105-14. PubMed ID: 10933918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A second dose of a CFTR cDNA-liposome complex is as effective as the first dose in restoring cAMP-dependent chloride secretion to null CF mice trachea.
    Goddard CA; Ratcliff R; Anderson JR; Glenn E; Brown S; Gill DR; Hyde SC; MacVinish LJ; Huang L; Higgins CF; Cuthbert AW; Evans MJ; Colledge WH
    Gene Ther; 1997 Nov; 4(11):1231-6. PubMed ID: 9425447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimisation of real-time quantitative RT-PCR for the evaluation of non-viral mediated gene transfer to the airways.
    Rose AC; Goddard CA; Colledge WH; Cheng SH; Gill DR; Hyde SC
    Gene Ther; 2002 Oct; 9(19):1312-20. PubMed ID: 12224014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gene therapy of hereditary diseases].
    Ginter EK
    Vopr Med Khim; 2000; 46(3):265-78. PubMed ID: 11033886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual therapeutic utility of proteasome modulating agents for pharmaco-gene therapy of the cystic fibrosis airway.
    Zhang LN; Karp P; Gerard CJ; Pastor E; Laux D; Munson K; Yan Z; Liu X; Godwin S; Thomas CP; Zabner J; Shi H; Caldwell CW; Peluso R; Carter B; Engelhardt JF
    Mol Ther; 2004 Dec; 10(6):990-1002. PubMed ID: 15564131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of CFTR from a ciliated cell-specific promoter is ineffective at correcting nasal potential difference in CF mice.
    Ostrowski LE; Yin W; Diggs PS; Rogers TD; O'Neal WK; Grubb BR
    Gene Ther; 2007 Oct; 14(20):1492-501. PubMed ID: 17637798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant adeno-associated virus vectors for cystic fibrosis gene therapy.
    Flotte TR
    Curr Opin Mol Ther; 2001 Oct; 3(5):497-502. PubMed ID: 11699895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An immunocytochemical assay to detect human CFTR expression following gene transfer.
    Davidson H; Wilson A; Gray RD; Horsley A; Pringle IA; McLachlan G; Nairn AC; Stearns C; Gibson J; Holder E; Jones L; Doherty A; Coles R; Sumner-Jones SG; Wasowicz M; Manvell M; Griesenbach U; Hyde SC; Gill DR; Davies J; Collie DD; Alton EW; Porteous DJ; Boyd AC
    Mol Cell Probes; 2009 Dec; 23(6):272-80. PubMed ID: 19615439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.